About FDA

Division of Non-Prescription Drugs and Health Fraud

Director: Elizabeth Miller, Pharm.D.

Branch Chief, Over-the-Counter Drugs Branch: Anuj Shah, J.D.

Branch Chief, Health Fraud and Consumer Outreach Branch: Brad Pace, J.D. 

Project Management Officer: Sudha Shukla, Pharm.D.  

The Division of Non-Prescription Drugs and Health Fraud (DNPDHF) directs field inspections and investigations and recommends, directs and/or coordinates case development and compliance actions related to both fraudulent drug products and OTC drug products.  In addition, DNPDF provides enforcement and litigation support and guidance relating to these products.   

DNPDHF uses risk-based assessments to identify and prioritize fraudulent and OTC drug products for regulatory action and develops compliance strategies to address violations.  DNPDHF also reviews and develops legislative proposals and implements regulations, policy documents, enforcement strategies, and outreach activities related to these drug products.

For additional information, please visit:

Page Last Updated: 12/15/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.